We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
-1.06%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$60.5B
AUM Growth
-$6.65B
(-9.9%)
Cap. Flow
-$4.05B
Cap. Flow
% of AUM
-6.69%
Top 10 Holdings %
Top 10 Hldgs %
13%
Holding
3,423
New
759
Increased
973
Reduced
920
Closed
697
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$509M |
| 2 |
Mastercard
MA
|
+$404M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$401M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$302M |
| 5 |
Intuit
INTU
|
+$277M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$416M |
| 2 |
Coca-Cola
KO
|
+$394M |
| 3 |
Starbucks
SBUX
|
+$374M |
| 4 |
Salesforce
CRM
|
+$351M |
| 5 |
PNC Financial Services
PNC
|
+$268M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.34% |
| 2 | Financials | 9.88% |
| 3 | Consumer Discretionary | 8.94% |
| 4 | Industrials | 7.09% |
| 5 | Healthcare | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
McKesson
MCK
$100B
| $580K | ﹤0.01% |
862
-49,156
| -98% | -$30.4M |
|
2202
Corcept Therapeutics
CORT
$12.1B
| $578K | ﹤0.01% |
5,064
-4,416
| -47% | -$269K |
|
2203
Nektar Therapeutics
NKTR
$2.59B
| $578K | ﹤0.01% |
+56,674
| New | +$740K |
|
2204
TTM Technologies
TTMI
$14.9B
| $575K | ﹤0.01% |
28,041
-77,527
| -73% | -$1.87M |
|
2205
QCR Holdings
QCRH
$1.74B
| $574K | ﹤0.01% |
+8,050
| New | +$613K |
|
2206
CALL
D.R. Horton
DHI
$41.6B
| $572K | ﹤0.01% |
4,500
-400
| -8% | -$53.6K |
|
2207
Brown & Brown
BRO
$23.6B
| $572K | ﹤0.01% |
4,595
-682,500
| -99% | -$76.3M |
|
2208
Select Water Solutions
WTTR
$2.69B
| $572K | ﹤0.01% |
+54,434
| New | +$660K |
|
2209
Xometry
XMTR
$5.43B
| $569K | ﹤0.01% |
+22,847
| New | +$718K |
|
2210
Kforce
KFRC
$1.04B
| $568K | ﹤0.01% |
11,614
-29,199
| -72% | -$1.52M |
|
|
EXE
2211
CALL
Expand Energy Corp
EXE
$21.9B
| $568K | ﹤0.01% |
+5,100
| New | +$531K |
|
2212
Viavi Solutions
VIAV
$10.7B
| $566K | ﹤0.01% |
50,612
-3,924
| -7% | -$43.7K |
|
2213
US Bancorp
USB
$102B
| $562K | ﹤0.01% |
13,306
+7,602
| +133% | +$351K |
|
2214
PUT
Seagate
STX
$208B
| $561K | ﹤0.01% |
6,600
-103,800
| -94% | -$9.81M |
|
2215
Treace Medical Concepts
TMCI
$309M
| $560K | ﹤0.01% |
66,748
+55,025
| +469% | +$495K |
|
2216
LPL Financial
LPLA
$29.4B
| $560K | ﹤0.01% |
1,711
-469,777
| -100% | -$164M |
|
2217
Repay Holdings
RPAY
$308M
| $559K | ﹤0.01% |
100,388
+25,291
| +34% | +$174K |
|
2218
CALL
Prudential Financial
PRU
$42.7B
| $558K | ﹤0.01% |
5,000
| – | – |
|
2219
NCR Atleos
NATL
$3.46B
| $557K | ﹤0.01% |
+21,121
| New | +$628K |
|
2220
Ocular Therapeutix
OCUL
$2.23B
| $556K | ﹤0.01% |
75,869
-21,684
| -22% | -$167K |
|
2221
PUT
TG Therapeutics
TGTX
$7.4B
| $556K | ﹤0.01% |
+14,100
| New | +$474K |
|
2222
CALL
HDFC Bank
HDB
$120B
| $551K | ﹤0.01% |
16,600
+8,000
| +93% | +$244K |
|
2223
BioMarin Pharmaceuticals
BMRN
$13.4B
| $548K | ﹤0.01% |
7,747
-329,356
| -98% | -$22.2M |
|
2224
Peoples Bancorp
PEBO
$1.49B
| $546K | ﹤0.01% |
18,420
+11,646
| +172% | +$366K |
|
2225
Quantum Computing Inc
QUBT
$2B
| $544K | ﹤0.01% |
+68,047
| New | +$599K |
|
Similar funds
BC
Balyasny Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Balyasny Asset Management held 3,423 positions worth $60.5B, down 9.9% from $67.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Balyasny Asset Management withdrew a net $4.05B in Q1 2025, closing 697 positions and reducing 920 holdings. Its most notable exit was Starbucks, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Balyasny Asset Management opened a new position in AutoZone worth $255M.
- Balyasny Asset Management's largest Q1 2025 buy was AutoZone: 66,934 shares worth $255M.
- Balyasny Asset Management added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $509M increase.
- Balyasny Asset Management's biggest Q1 2025 reduction was Arthur J. Gallagher & Co, cutting an estimated $416M.
- Balyasny Asset Management fully exited Starbucks in Q1 2025, selling an estimated $374M.
- Balyasny Asset Management's ten largest holdings make up 13% of its $60.5B portfolio in Q1 2025.
- Balyasny Asset Management opened 759 new positions and closed 697 in Q1 2025.
- Balyasny Asset Management's portfolio value fell 9.9% quarter-over-quarter to $60.5B.
Based on Balyasny Asset Management's 13F filing for Q1 2025, filed 15 May 2025.